Invited Commentary

Commentary on "Implementing High-Value Care"

Authors: Michael A. Thomas, MD

Abstract

In this issue of the Southern Medical Journal, Lane and colleagues present an anonymous survey study that had a simple set of objectives.1 The first was to determine whether women’s health providers knew the costs of the medications that are commonly used in the hospital setting, whether individual medications routinely ordered were actually necessary, and whether a less expensive alternative could be found. In their investigation, 71% of providers completed the questionnaire, which is a much higher response rate than most published survey studies. When targeting two obstetrical medications (hydrocortisone acetate/pramoxine hydrochloride and dinoprostone vaginal inserts), these researchers were able to demonstrate that when these medications were taken off standing orders or when a less expensive oral alternative was given, the overall cost savings was almost $160,000.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Demosthenes LD, Lane AS, Blackhurst DW. Implementing high-value care. South Med J 2015;108:645-648.
 
2. Wall LL, Brown D. The high cost of free lunch. Obstet Gynecol 2007;110:169-173.
 
3. Saul S. Drug makers pay for lunch as they pitch. http://www.nytimes.com/2006/07/28/business/28lunch.html?pagewanted=all&_r=0. Published July 26, 2006. Accessed September 3, 2015.